Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB08879
http://purl.obolibrary.org/obo/dinto_DB08879
|
|---|---|
| Preferred Name | belimumab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | belimumab
|
|---|---|
| label | belimumab
|
| ATCCode | L04AA26
|
| Definition | Belimumab is an intravenous immunosupressant for the adjunctive treatment of systemic lupus erythematosus (SLE). More specifically, it is a fully human recombinant monoclonal IgG antibody and is the first biological treatment approved for this indication (SLE). Avoid concomitant use with live or inactivated vaccines. FDA approved on March 9, 2011.
|
| has pharmacological target | |
| type | |
| AHFScode | 92:44
|
| xref |
National Drug Code Directory:49401-101-01
Drugs.com:http://www.drugs.com/ppa/belimumab.html
Wikipedia:http://en.wikipedia.org/wiki/Belimumab
RxList:http://www.rxlist.com/benlysta-drug.htm
|
| CASRN | 356547-88-1
|
| prefixIRI | obo2:dinto_DB08879
|
| related with | |
| may interact with | |
| DBBrand | benlysta
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |